Robert Kennedy jnr: Pharma investors brace for impact
Vaccine makers and companies manufacturing breakthrough obesity drugs saw share prices fall on nomination
Biontech
Pfizer shares tumble on weak forecast for 2024 revenues
US drugmaker is trying to chart its future without blockbuster Covid-19 products
New therapy ‘highly effective’ in patients with ovarian cancer, says BioNTech
German pharmaceutical company shot to fame as first company to produce a next-generation mRNA vaccine to treat Covid-19
FDA approves new Covid boosters as cases rise around US
Hospitalisations from Covid-19 have crept up in recent weeks, although the rise is lower than the same time last year
Slump in demand for Covid medications behind fall in Irish pharma exports
Pfizer’s second-quarter results confirm sharp fall in demand for vaccines and other Covid medicines produced in Ireland
BioNTech/Pfizer’s mooted EU deal for 70m Covid shots threatens rivals
European health officials have advocated portfolio diversity to help fight different variants
Eli Lilly warns EU will miss out on key drugs under new patent rules
Chief executive says draft plan to cut market exclusivity protection could make pursuing some treatments unviable
Biontech sees some vaccine deliveries shifting to next year
Sales drop 43% in third quarter as primary immunisation drives reach completion
Vaccine makers face revenue slump as demand falls for Covid-19 jabs
Pharmaceutical companies hunt for new revenue streams as pandemic becomes endemic
Investors ditch vaccine stocks after Joe Biden says ‘pandemic is over’
Top jab makers lose combined $10bn of market value amid fears over growing public apathy
Moderna accuses BioNTech/Pfizer of copying mRNA technology
US biotech claims rival Covid vaccine makers infringed patents underpinning jabs
BioNTech sinks as Covid vaccine sales and profit disappoint
Group still expects to hit a target of €13-17bn in vaccine revenues this year, with demand increasing in the fourth quarter
Truth in vaccine access row can be as tricky to find as a needle
Waning demand threatens efforts to produce vaccine locally so perhaps education is the priority
EU regulator backs Pfizer Covid shot as booster after other vaccines
Recommendation comes as global cases of virus top 500m amid Omicron surge
Pandemic wind-down reveals vaccine winners
Cantillon: Emerging markets surprise observers with vaccine preferences
Chief executives of mRNA vaccine groups earn $100m in pandemic pay
Bosses of Pfizer, BioNTech and Moderna also see paper wealth grow as share prices surge
Children aged 12-15 to be offered a booster dose of Covid-19 vaccine
Another 11,671 PCR-confirmed coronavirus cases reported in past few days
EU Commission accused of maladministration by ombudsman over Pfizer CEO texts
Emily O’Reilly criticises executive for not disclosing Von Der Leyen messages
Pfizer and BioNTech launch trial of Omicron-targeted Covid vaccine in US
Companies to test fourth dose of current vaccine against fourth dose of new one
How a lab scientist’s bad cold led to the ‘marvel’ mRNA vaccine
Dr Barney Graham’s discovery was a key step in development of Covid-19 vaccines
Novartis to seek speedy approval for Covid drug after positive trials
In lab tests the drug maintained its antiviral activity against all variants of concern
Pfizer and BioNTech team up to develop mRNA-based shingles vaccine
Drugmakers hope to build on success of Covid vaccine
Five economic flashpoints to watch out for in 2022
Next year may bring good news but many of the concerns of 2021 will not have gone away
Booster doses for under-40s not expected until after Christmas
Next phase of vaccination programme in January complicated by multiple rollouts
Q&A: Covid vaccine boosters – who is eligible, where to get them, which dose is offered
More than 1.3 million boosters are given in State so far in race against highly contagious Omicron variant
Current vaccine boosters protect against Omicron, says Fauci
Data shows no need for variant-specific vaccines, says Biden’s chief medical adviser
HSE rolls out information campaign on children’s Covid vaccines
Registration for ages five to 11 will open shortly, with priority for those more at risk
Pfizer booster provides significant protection against Omicron variant – study
Israeli research compared blood samples between two-dose group and booster group
Covid booster shots up to 75% effective against Omicron, UK study finds
Omicron expected to overtake the dominant Delta variant in the UK ‘by mid-December’
Omicron chill continues to hold back equity markets
US indices rise as inflation report is in line with expectations
World stocks rally stalls at two-week highs
Increased restrictions to contain the Omicron coronavirus variant temper optimism
Shares fall across Europe as UK signals further Covid curbs
‘Yo-yo day’ prevails on Dublin stock market
Booster shot neutralises Omicron, Pfizer and BioNTech say
Third vaccine dose as effective as second shot was in fighting original virus, study finds
EU expects Europe plants to produce 3.6 billion Covid shots in 2022
Total global output will be more than 20 billion shots for the year
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
The GlossOpens in new window
Read the digital edition of The Gloss magazine now
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices